Extend Biosciences Inc.

Address

1 Kendall Sq. Bldg. 200, Suite 2203
Cambridge, MA, 02139-

http://WWW.EXTENDBIO.COM

Information

DUNS: 963416420
# of Employees: 2

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: Y

Award Charts




Award Listing

  1. Long-acting ghrelin for the treatment of ARS

    Amount: $300,000.00

    Project Summary The threat of a radiation attack or accident is unfortunately all too real and could potentially affect a large enough population so as to overwhelm the medical system To be prepare ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  2. Long acting PTH for hypoparathyroidism

    Amount: $306,738.00

    DESCRIPTION provided by applicant Hypoparathyroidism is a rare disease that results from a deficiency or inability to make sufficient amounts of parathyroid hormone PTH Untreated or inadequately ...

    SBIRPhase I2015Department of Health and Human Services
  3. SBIR Phase II: A platform technology that significantly improves drug delivery

    Amount: $741,634.00

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is the development of a drug delivery platform that can improve a drug?s properties such that ...

    SBIRPhase II2015National Science Foundation
  4. Enhancing the Pharmacokinetic Profile of Protein-based Drugs

    Amount: $999,998.00

    Many protein-based drugs have limited efficacy due to a short half-life or require intravenous delivery because of low bioavailability. Extend Biosciences is developing proprietary carrier molecules t ...

    SBIRPhase II2014Department of Defense
  5. Enhancing the Pharmacokinetic Profile of Protein-based Drugs

    Amount: $99,999.00

    Many protein-based drugs have limited efficacy due to a short half-life or require intravenous delivery because of low bioavailability when given subcutaneously. Extend Biosciences is developing propr ...

    SBIRPhase I2013Department of Defense
  6. Monitor for Multiple Biomarkers for Detection of Alcohol Consumption

    Amount: $449,649.00

    DESCRIPTION (provided by applicant): Chronic alcohol consumption can cause progressive liver damage, resulting in steatohepatitis and cirrhosis, which can lead to other more fatal complications such a ...

    SBIRPhase I2013Department of Health and Human Services
  7. Efficacy and Safety of an Aerosolized Recombinant Butyrylcholinesterase Pretreatm

    Amount: $288,302.00

    DESCRIPTION (provided by applicant): Cachexia is a complex syndrome characterized by involuntary weight loss and skeletal muscle wasting that leads to fatigue, weakness and a loss of appetite that is ...

    SBIRPhase I2013Department of Health and Human Services
  8. SBIR Phase I: Carriers for Improved Drug Delivery of Biopharmaceuticals

    Amount: $150,000.00

    This Small Business Innovation Research (SBIR) Phase I project will develop a platform technology that improves drug delivery. Many drugs, such as blood factors, require frequent dosing because they d ...

    SBIRPhase I2013National Science Foundation

Agency Micro-sites

US Flag An Official Website of the United States Government